Results 131 to 140 of about 5,209 (179)
Some of the next articles are maybe not open access.
CD30-targeting immunoconjugates and bystander effects
Nature Reviews Clinical Oncology, 2015Yoshiki Sawa +2 more
exaly
Are immunoconjugates approaching “standard of care” in AML?
Best Practice and Research in Clinical Haematology, 2013Elihu Estey
exaly
Arming antibodies: prospects and challenges for immunoconjugates
Nature Biotechnology, 2005Anna M Wu +2 more
exaly

